Anesthesia/facial pain
Association Between Polymorphisms in the Genes of Estrogen Receptors and the Presence of Temporomandibular Disorders and Chronic Arthralgia

https://doi.org/10.1016/j.joms.2017.10.023Get rights and content

Purpose

The high prevalence of painful temporomandibular disorders (TMDs) in women suggests that estrogen and its receptors play a fundamental etiologic role in the development of this joint pathology through complex action mechanisms. The aim of this study was to evaluate the possible association between polymorphisms in the ESR1 (estrogen receptor-1) and ESRRB (estrogen-related receptor-β) genes and the risk of simultaneous development of TMDs and pain in other joints in the body.

Materials and Methods

All participants were clinically evaluated for the presence of TMD (Research Diagnostic Criteria for TMD) and asked about the presence of chronic joint pain. The control group consisted of 72 patients without TMD and without pain. Participants with arthralgia were divided into 3 groups: with muscular TMD (n = 42), with articular TMD (n = 16), and without TMD and with systemic arthralgia (n = 82). Eight single-nucleotide polymorphisms in the ESR1 (rs12154178, rs1884051, rs2273206, rs7774230) and ESRRB (rs1676303, rs4903399, rs10132091, rs7151924) genes were investigated. The χ2 test and Student t and Mann-Whitney tests were used to assess the relevance of nominal and continuous variables, respectively. A P value less than .05 was considered significant.

Results

The TT (timin/timin) genotype for the ESR1 (rs2273206) gene was strongly associated with the risk of developing muscle TMDs and temporomandibular joint pain (P = .04). For the ESRRB (rs1676303) gene, an association was observed between the CC (cytosine/cytosine) genotype and the presence of articular TMDs associated with other chronic arthralgia (P = .02). These results were confirmed by the increased risk of developing articular TMDs associated with the C allele (P = .04).

Conclusions

This study supports the hypothesis that changes in the ESR1 and ESRRB genes influence the presence of TMDs associated with chronic joint pain.

Section snippets

Materials and Methods

This is a descriptive cross-sectional randomized study that was approved on May 30, 2013 by the research ethics committee of the Salgado de Oliveira University (Niterói, RJ, Brazil; opinion number 286.354). Free and informed consent was obtained from participants in writing before conducting the research. Recommendations from the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)27 statement were followed for the design and development of this study.

Study subjects

Clinical Findings: Prevalence of TMD and Other Arthralgia

Of 337 volunteers evaluated during a 2-year period, 212 were included in the study. Of these, 58 (32 women [55.2%] and 26 men [44.8%]) had TMDs and other arthralgia. Of the TMD subgroups, 42 (33%) had only muscular disorders and 16 (12.5%) had only joint disorders. The group without TMD but with other chronic joint pain (n = 82) was composed of 52 women (63.4%) and 30 men (36.6%). The control group was composed of 72 participants (39 women [54.2%] and 33 men [45.8%]) without articular symptoms

Discussion

The function of estrogen in the development and perpetuation of chronic pain based on genomic mechanisms (determined by their interaction with nuclear ER-α and ER-β) and non-genomic mechanisms (involving G protein-coupled receptors)4 has been extensively explored. However, the high prevalence of osteoarthritis in postmenopausal women raised interest in how such receptors might act not only in the perception and processing of painful stimuli33 but also in the homeostasis of articular tissues.34

References (46)

  • A. Amandusson et al.

    Estrogen-induced alterations of spinal cord enkephalin gene expression

    Pain

    (1999)
  • M. Jia et al.

    Estrogen receptor alpha and beta in health and disease

    Best Pract Res Clin Endocrinol Metab

    (2015)
  • J.W. Younger et al.

    Chronic myofascial temporomandibular pain is associated with neural abnormalities in the trigeminal and limbic systems

    Pain

    (2010)
  • C.C. Teerlink et al.

    Significant association of full-thickness rotator cuff tears and estrogen-related receptor-β (ESRRB)

    J Shoulder Elbow Surg

    (2015)
  • G.R. Motta et al.

    Evidence of genetic variations associated with rotator cuff disease

    J Shoulder Elbow Surg

    (2014)
  • H. Claassen et al.

    Immunohistochemical detection of estrogen receptor alpha in articular chondrocytes from cows, pigs and humans: In situ and in vitro results

    Ann Anat

    (2001)
  • A.H. Chalkoo et al.

    Possible role of estrogen in temporomandibular disorders in female subjects: A research study

    J Indian Acad Oral Med Radiol

    (2014)
  • S.R. Patil et al.

    Role of female reproductive hormones estrogen and progesterone in temporomandibular disorder in female patients

    J Oral Res Rev

    (2015)
  • S.F.S. Moreira et al.

    Effects of melatonin and estradiol on chronic pain during postmenopause

    Clin Biomed Res

    (2014)
  • I.P. Braidman et al.

    Localization of estrogen receptor beta protein expression in adult human bone

    J Bone Miner Res

    (2001)
  • W. Dietrich et al.

    Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia

    J Soc Gynecol Investig

    (2006)
  • P. Sciore et al.

    Identification of sex hormone receptors in human and rabbit ligaments of the knee by reverse transcription polymerase chain reaction: Evidence that receptors are present in tissue from both male and female subjects

    J Orthop Res

    (1998)
  • T. Räsänen et al.

    Articular cartilage compressive stiffness following oophorectomy or treatment with 17β-estradiol in young postpubertal rabbits

    Acta Obstet Gynecol Scand

    (1999)
  • Cited by (12)

    • Genetic overlap between temporomandibular disorders and primary headaches: A systematic review

      2022, Japanese Dental Science Review
      Citation Excerpt :

      EPHPP Quality Assessment Tool was used for randomized controlled trials. From the included studies, a brief description of the study design and sample is provided, followed by identifying the genes involved in the pathophysiology of either PHD (Table 3) [29–80] or TMD (Table 4) [81–107] and their respective pathways. Then, the main findings and the associated conclusions are reported.

    • Gender differences in Damp-Heat Syndrome: A review

      2021, Biomedicine and Pharmacotherapy
    • Morphology of the temporomandibular joints regarding the presence of osteoarthritic changes

      2020, International Journal of Environmental Research and Public Health
    View all citing articles on Scopus

    Financial support of this work was provided by the School of Medicine of Petrópolis.

    Conflict of Interest Disclosures: None of the authors have a relevant financial relationship(s) with a commercial interest.

    View full text